Fermenta Biotech Limited's AGM confirmed audited financial statements, dividend approval, director appointments, and auditor remuneration. All resolutions passed with strong shareholder support.
Fermenta Biotech reports record revenue of ₹548 Cr, up 14%. Core EBITDA grew 44% driven by strong operating leverage and growth across all businesses. Approved ₹110 Cr capex for new Dahej capacity.
Fermenta Biotech sees flat revenue QoQ, down 13% YoY at INR 126.2 Cr. Human nutrition volumes up 18% QoQ, while India's share of revenue increased to 47%. VITADEE Green® received FSSAI approval.
Fermenta Biotech is now listed on the NSE, alongside its BSE listing. This dual listing aims to enhance investor accessibility and market visibility for the company.
